US Stock MarketDetailed Quotes

CRVO CervoMed

Watchlist
  • 9.480
  • +0.980+11.53%
Close Mar 28 16:00 ET
  • 9.630
  • +0.150+1.58%
Post 19:59 ET
82.50MMarket Cap-4.69P/E (TTM)

CervoMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
133.30%18.23M
191.92%7.24M
101.72%5.4M
143.31%3M
81.93%2.59M
124.80%7.81M
164.21%2.48M
195.90%2.68M
-71.01%1.23M
-68.68%1.43M
Selling and administrative expenses
40.61%9.17M
9.48%2.32M
-8.27%2.21M
153.05%2.51M
112.60%2.13M
204.77%6.52M
279.06%2.12M
320.24%2.41M
-53.56%992.55K
-52.98%1M
-General and administrative expense
40.61%9.17M
9.48%2.32M
-8.27%2.21M
153.05%2.51M
112.60%2.13M
204.77%6.52M
279.06%2.12M
320.24%2.41M
-53.56%992.55K
-52.98%1M
Research and development costs
122.77%18.8M
148.19%7.09M
186.08%5.13M
92.63%3.77M
53.51%2.81M
531.40%8.44M
650.06%2.86M
441.98%1.79M
-7.12%1.96M
-24.43%1.83M
Other operating expenses
-36.29%-9.74M
13.19%-2.16M
-27.07%-1.94M
-91.23%-3.29M
-66.72%-2.35M
---7.14M
---2.49M
---1.53M
---1.72M
---1.41M
Operating profit
-133.30%-18.23M
-191.92%-7.24M
-101.72%-5.4M
-143.31%-3M
-81.93%-2.59M
-124.80%-7.81M
-164.21%-2.48M
-195.90%-2.68M
71.01%-1.23M
68.68%-1.43M
Net non-operating interest income expense
782.94%1.94M
348.52%532.18K
1,255.60%646.17K
3,731.48%678.44K
127.75%80.63K
255.99%219.43K
276.89%118.65K
121.51%47.67K
-68.03%17.71K
27.31%35.4K
Non-operating interest income
782.94%1.94M
348.52%532.18K
1,255.60%646.17K
3,731.48%678.44K
127.75%80.63K
252.63%219.43K
269.99%118.65K
121.51%47.67K
-68.03%17.71K
27.31%35.4K
Other net income (expense)
-100.02%-991
554.33%2.73K
-100.07%-3.44K
99.88%-247
-100.00%-30
326.93%5.42M
99.90%-600
5,429,445.45%4.78M
-212.21K
856.58K
Other non- operating income (expenses)
-100.02%-991
554.33%2.73K
-100.07%-3.44K
99.88%-247
-100.00%-30
326.93%5.42M
99.90%-600
5,429,445.45%4.78M
---212.21K
--856.58K
Income before tax
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
343.63%2.15M
65.98%-1.43M
88.20%-534.34K
Income tax
Net income
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
343.63%2.15M
65.98%-1.43M
88.20%-534.34K
Net income continuous Operations
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
343.63%2.15M
65.98%-1.43M
88.20%-534.34K
Minority interest income
Net income attributable to the parent company
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
343.63%2.15M
65.98%-1.43M
88.20%-534.34K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
343.63%2.15M
65.98%-1.43M
88.20%-534.34K
Basic earnings per share
-146.34%-2.02
-92.16%-0.8
-184.62%-0.55
90.18%-0.27
60.19%-0.41
92.68%-0.82
85.89%-0.4163
138.24%0.65
11.00%-2.75
69.07%-1.03
Diluted earnings per share
-146.34%-2.02
-92.16%-0.8
21.43%-0.55
90.18%-0.27
60.19%-0.41
92.68%-0.82
85.89%-0.4163
58.82%-0.7
11.00%-2.75
69.07%-1.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 133.30%18.23M191.92%7.24M101.72%5.4M143.31%3M81.93%2.59M124.80%7.81M164.21%2.48M195.90%2.68M-71.01%1.23M-68.68%1.43M
Selling and administrative expenses 40.61%9.17M9.48%2.32M-8.27%2.21M153.05%2.51M112.60%2.13M204.77%6.52M279.06%2.12M320.24%2.41M-53.56%992.55K-52.98%1M
-General and administrative expense 40.61%9.17M9.48%2.32M-8.27%2.21M153.05%2.51M112.60%2.13M204.77%6.52M279.06%2.12M320.24%2.41M-53.56%992.55K-52.98%1M
Research and development costs 122.77%18.8M148.19%7.09M186.08%5.13M92.63%3.77M53.51%2.81M531.40%8.44M650.06%2.86M441.98%1.79M-7.12%1.96M-24.43%1.83M
Other operating expenses -36.29%-9.74M13.19%-2.16M-27.07%-1.94M-91.23%-3.29M-66.72%-2.35M---7.14M---2.49M---1.53M---1.72M---1.41M
Operating profit -133.30%-18.23M-191.92%-7.24M-101.72%-5.4M-143.31%-3M-81.93%-2.59M-124.80%-7.81M-164.21%-2.48M-195.90%-2.68M71.01%-1.23M68.68%-1.43M
Net non-operating interest income expense 782.94%1.94M348.52%532.18K1,255.60%646.17K3,731.48%678.44K127.75%80.63K255.99%219.43K276.89%118.65K121.51%47.67K-68.03%17.71K27.31%35.4K
Non-operating interest income 782.94%1.94M348.52%532.18K1,255.60%646.17K3,731.48%678.44K127.75%80.63K252.63%219.43K269.99%118.65K121.51%47.67K-68.03%17.71K27.31%35.4K
Other net income (expense) -100.02%-991554.33%2.73K-100.07%-3.44K99.88%-247-100.00%-30326.93%5.42M99.90%-6005,429,445.45%4.78M-212.21K856.58K
Other non- operating income (expenses) -100.02%-991554.33%2.73K-100.07%-3.44K99.88%-247-100.00%-30326.93%5.42M99.90%-6005,429,445.45%4.78M---212.21K--856.58K
Income before tax -650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M343.63%2.15M65.98%-1.43M88.20%-534.34K
Income tax
Net income -650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M343.63%2.15M65.98%-1.43M88.20%-534.34K
Net income continuous Operations -650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M343.63%2.15M65.98%-1.43M88.20%-534.34K
Minority interest income
Net income attributable to the parent company -650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M343.63%2.15M65.98%-1.43M88.20%-534.34K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M343.63%2.15M65.98%-1.43M88.20%-534.34K
Basic earnings per share -146.34%-2.02-92.16%-0.8-184.62%-0.5590.18%-0.2760.19%-0.4192.68%-0.8285.89%-0.4163138.24%0.6511.00%-2.7569.07%-1.03
Diluted earnings per share -146.34%-2.02-92.16%-0.821.43%-0.5590.18%-0.2760.19%-0.4192.68%-0.8285.89%-0.416358.82%-0.711.00%-2.7569.07%-1.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion------------------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Zhejiang Huaye Plastics Machinery
301616
+38.11%
Alnera Aluminium
301613
+20.00%
Tibet Duo Rui Pharmaceutical
301075
+19.99%
4
Shenzhen Vital New Material
301319
+19.99%
5
ChengDu Sheng Nuo Biotec
688117
+19.98%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings